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The published evidence concerning the safety, eﬃcacy, and patient satisfaction for implantation of the current model of the
artiﬁcial urinary sphincter (AS 800) in men with post prostatectomy urinary incontinence was the objective of this review. A
Pub Med English language literature search from 1995 to 2011 was performed. A majority of men who undergo AUS implantation
for post prostatectomy urinary incontinence achieve satisfactory results (0 to 1 pad per day). Infection rates range from 0.46 to
7%, cuﬀ erosion rates range from 3.8 to 10%, and urethral atrophy ranges from 9.6 to 11.4%. Kaplan-Meier 5 year projections for
freedomfromanyreoperationwere50%forasmallseriesand79.4%foralargerseries.Kaplan-Meierprojectionsforfreedomfrom
mechanical failure were 79% at 5 years and 72% at 10 years. In another series 10 year projections for freedom from mechanical
failure were 64%. Although the artiﬁcial urinary sphincter (AUS) is the gold standard for the treatment of this disorder, most men
will continue to need at least one pad per day for protection, and they are subject to a signiﬁcant chance of future AUS revision or
replacement.
1.Introduction
There is a wide range in the reported incidence of postradical
prostatectomy urinary incontinence coming from individ-
ual series presumably due to inconsistent deﬁnitions of
incontinence and diﬀering modes of assessment. When
large populations of postradical prostatectomy patients are
surveyed, however, a more consistent pattern is observed.
In a series of 1291 postprostatectomy patients, signiﬁcant
urinary incontinence persisted in 8.4% of men at eighteen
months [1]. In a more recent NEJM study of 557 men at 12
months after radical prostatectomy, 24% were using pads,
and 8% classiﬁed this as a moderate or big problem [2].
Urinary incontinence occurs less often after transurethral
resection of the prostate being a signiﬁcant problem in only
0.5% of 3885 men 2 months following surgery [3].
The artiﬁcial urinary sphincter (AUS) is widely regarded
as the gold standard for the treatment of post prostatectomy
urinary incontinence [4]. This prosthetic device was ﬁrst
introduced in 1973 [5], and during the next 10 years there
were design changes resulting in 5 diﬀerent models of the
device[6].TheﬁfthmodeloftheAUS,theAS800(American
Medical Systems, Minnetonka, MN, USA) was introduced
in 1983 and is still in use today. The AS 800 has 3 separate
components: a cuﬀ, a pressure regulating balloon, and a
pump-control assembly (Figure 1). The components are
implanted separately and connected by 2 tubing connectors.
For post prostatectomy urinary incontinence, the cuﬀ is
placed around the bulbous urethra, the pressure regulating
balloon is usually placed in the retropubic space, and the
pump-control assembly is placed in the scrotum.
Since 1983 the basic design of the AUS has been
unchanged; however, there have been numerous modiﬁ-
cations to device components leading to both increased
continence and longer device life. These component changes
include narrow back cuﬀs for bulbous urethral use, smaller
(3.5 and 4.0cm) cuﬀs, surface-coated cuﬀst or e d u c ew e a r ,
kink-resistant tubing, tubing sleeves to reduce wear, and
sutureless connectors to facilitate making connections and to
reduce connector failures.2 Advances in Urology
Figure 1: AS 800 (Used by permission of American Medical
Systems, Minnetonka, MN, USA).
2.MaterialsandMethods
A PubMed English language literature search from 1995
through 2011 for keywords: artiﬁcial sphincter; urinary
sphincter, artiﬁcial; prosthesis failure; prostatectomy/ae
[adverse eﬀects]; patient satisfaction; quality of life was
performed. Thirteen articles were found where data relevant
to patients with post prostatectomy incontinence could be
separatedfromotherAUSuses.Thesearticleswereexamined
to perform this paper.
3. Results
3.1. Eﬃcacy. There is no standardization for reporting pre-
andpost-AUSlevelsofincontinence.Inastudyof50patients
with a median followup of 23.4 months, the preoperative
levels of incontinence were such that 70% wore an average of
6 diapers a day, and 24% wore an average of 7.4 pads per day
[7]. After AUS implantation, 20% had complete continence.
Of the remainder, 55% had leakage of a few drops, daily, and
22% had leakage of less than a teaspoonful.
In a study of 54 men with mean follow-up of 7.2 years,
54% were socially continent (0 to 1 pad per day). Mean pad
score before AUS implantation was 2.75, and it decreased to
0.97 after AUS implantation [8].
In a group of 113 patients with mean follow-up of 73
months (range 20 to 170), 32% were pad free, 33% used 1
pad per day, 14% used 2 pads per day, 17% used 3 pads per
day, and 5% used more than 3 pads per day [9].
In a study of 33 men aged 75 years or greater with an
average follow-up of 5 years, mean pad use decreased from
6.7 pads per day (range 3–10) to 0.8 pads per day (range 0–2)
[10].
In a study comparing 435 ﬁrst time AUS implants to 119
repeat AUS implants, pad use of 0 to 1 day was noted in 90%
of the primary implants and 82% of the secondary implants
[11].
In 124 patients with a median follow-up of 6.8 years,
27.1% required no pads and 52.0% required 1 pad per day
after AUS implantation [12].
In a cohort of 71 men with mean follow-up of 7.7 years
(range0.5–16),27%usednopads,32%used1pad,15%used
1–3 pads, and 25% used more than 3 pads daily [13].
In a series of 40 men with mean follow-up of 53.4 ± 21.4
months (range 27–132), pad count decreased from 4.0 ± 0.9
to 0.62±1.07 per day, and on a visual analog scale the impact
of the incontinence decreased from 5.0 ± 0.7t o1 .4 ± 0.93
[14].
3.2.CuﬀErosion. Cuﬀerosion(Table 1)occurringwithinthe
ﬁrst few weeks or months following AUS implantation is
usually due to injury to the urethra when is mobilized prior
to cuﬀ placement. Late erosion usually occurs after a catheter
has been inserted for a prolonged period without proper
deactivation of the AUS. Unfortunately, very few reports of
cuﬀ erosion rates make the distinction between early and late
cuﬀ erosion.
3.3. Infection. AUS infection (Table 1) occurring without
cuﬀ erosion is not common. Most cuﬀ erosions will lead to
infection unless the erosion is detected early, and the AUS
is removed before infection occurs. Most reporting of AUS
infection fails to distinguish between infection alone and
infection occurring as the result of cuﬀ erosion.
3.4. Urethral Atrophy. When men achieve a satisfactory
level of continence following activation of their AUS (0
to 1 pad per day) and later a gradual increase in pad
use occurs, an AUS trouble shooting protocol should be
employed [16]. If other causes of increasing incontinence
have been ruled out by this protocol and the number of
pump cycles to completely empty the cuﬀ has increased,
then urethral atrophy under the cuﬀ has occurred. Possible
revision procedures for this problem include cuﬀ down
sizing [17], tandem cuﬀ placement [18], or transcorporeal
cuﬀ placement [19].
Urethral atrophy rates are shown in Table 1.
3.5. Mechanical Failure. For penile prosthesis implantation
the American Urological Association Erectile Guidelines
Committee has recommended that freedom from mechan-
ical failure be reported in terms of Kaplan-Meier projections
[20]. This allows meaningful comparisons within a single
series and among several series where individual patient
follow-up is variable. A similar recommendation should
be adopted for reporting mechanical failure and other
complications of AUS implantation.
Kaplan-Meier reporting was used in one series where 66
AUS implantation patients were available for a mean follow-
up of 41 months, The 5-year Kaplan-Meier projections for
freedom from any reoperation was 50% and for freedom
from any cuﬀ revision was 60% [21]. In another series of
124 patients with median follow-up of 6.8 years, the 10 year
Kaplan-Meier freedom from mechanical failure was 64%
[12].Inareportof530menthe5yearKaplan-Meierfreedom
from reoperation was 79.4%, for primary cases and 88%
for revision surgeries [11] .I naf o u r t hs e r i e so f3 9m e n
withbulbousurethralcuﬀAUSimplantations,Kaplan-MeierAdvances in Urology 3
Table 1
Reference N Mean followup
(months)
Infection
(%)
Cuﬀ erosion
(%)
Urethral atrophy
(%)
Device failure
(%) Removal/revision (%)
Lai et al. [15] 176 36.5 5.5 6.0 9.6 6.0 27.1
Kim et al. [12] 124 81.6 7 10 29 37
Raj et al. [11] 554 68 0.46 3.8 11.4 5.6 21.4
Gousse et al.
[13] 71 92.4 1.4 4 25 29
freedom from mechanical failure at 5 years was 79% and at
10 years it was 72% [22].
Mechanical failure rates for the remaining studies are
shown in Table 1.
3.6. AUS Implantation after Radiation Therapy. In one series,
58 men with AUS and no prior radiation (group 1) were
compared to 28 with AUS after radiation therapy for prostate
cancer (group 2) [23]. Mean follow-up was 31 ± 23 months
for group 1 and 36 ± 21 months for group 2. Reoperation
was required for 22.4% group 1 and 25% group 2. Urethral
atrophy occurred in 14% in both groups. Urethral erosion
occurred in 2% group 1 and 7% group 2. Infection occurred
in7%group1andnoneingroup2.Noneofthesediﬀerences
were statistically signiﬁcant. The degree of continence (0-1
pad per day) was similar for both groups, 60% and 64%.
In another study, 76 men with AUS implantation and no
radiation were compared to 22 men with AUS implantation
after radiation [24]. Urethral atrophy, infection, and erosion
were more common in the group with radiation (41%)
compared to the group without radiation (11%).
3.7. Patient Satisfaction. Ideal satisfaction studies would be
prospective and used standardized questionnaires admin-
istered pre- and post-operatively. In addition since incon-
tinence may have a signiﬁcant quality-of-life impact on
the partner, including partners in these studies would be
desirable. Unfortunately, nearly all studies are retrospective
and use a variety of nonvalidated satisfaction scales.
In a study of 50 patients with a median follow-up of 23.4
months, 90% reported satisfaction, 96% would recommend
AUS implantation to a friend, and 92% would have the AUS
placed again [7].
In a study of 54 men with mean follow-up of 7.2 years,
subjective improvement was 4.1, and overall satisfaction was
3.9 (scale 0 to 5) [8].
In a group of 113 patients with mean follow-up of 73
months (range 20 to 170), 28% were very satisﬁed, 45% were
satisﬁed, 18% were neutral, 6% were dissatisﬁed, and 4%
were very dissatisﬁed [9].
In 71 men with a mean follow-up of 7.7 years (range 0.5–
16), 58% were very satisﬁed, 19% were satisﬁed, and 23%
were unsatisﬁed [13].
4. Conclusions
Signiﬁcant urinary incontinence following radical prostatec-
tomywhichpersistsformorethanoneyearoccursinasmany
as 8% of men. Although the AUS is the gold standard for the
treatment of this disorder, most men will continue to need at
least one pad per day for protection, and they are subject to a
signiﬁcant chance of future AUS revision or replacement.
Current reporting of AUS implantation results is far
from ideal. Freedom from mechanical failure and other
complications should be reported in terms of Kaplan-Meier
projections. Quality-of-life and patient satisfaction studies
should be prospective, include partners, and use validated
questionnaires.
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